Patents by Inventor Eduard N. Lerner

Eduard N. Lerner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9492661
    Abstract: Transnasal delivery of medication directly to a patient's brain is achieved using an iontophoresis wire cooperable with a medication administration device. A controller regulates an electric charge to the iontophoresis wire. The iontophoresis wire is insertable into each nasal cavity. This wire is preferably encased in a tube, through which the medication will be transnasally delivered. A cleaning solution may also be delivered to the nasal cavity after treatment to reduce irritation from the iontophoresis.
    Type: Grant
    Filed: April 4, 2014
    Date of Patent: November 15, 2016
    Inventor: Eduard N. Lerner
  • Publication number: 20140221905
    Abstract: Transnasal delivery of medication directly to a patient's brain is achieved using an iontophoresis wire cooperable with a medication administration device. A controller regulates an electric charge to the iontophoresis wire. The iontophoresis wire is insertable into each nasal cavity. This wire is preferably encased in a tube, through which the medication will be transnasally delivered. A cleaning solution may also be delivered to the nasal cavity after treatment to reduce irritation from the iontophoresis.
    Type: Application
    Filed: April 4, 2014
    Publication date: August 7, 2014
    Inventor: Eduard N. Lerner
  • Patent number: 8718754
    Abstract: Transnasal delivery of medication directly to a patient's brain is achieved using an iontophoresis wire cooperable with a medication administration device. A controller regulates an electric charge to the iontophoresis wire. The iontophoresis wire is insertable into each nasal cavity. This wire is preferably encased in a tube, through which the medication will be transnasally delivered. A cleaning solution may also be delivered to the nasal cavity after treatment to reduce irritation from the iontophoresis.
    Type: Grant
    Filed: May 14, 2010
    Date of Patent: May 6, 2014
    Inventor: Eduard N. Lerner
  • Publication number: 20120065577
    Abstract: Transnasal delivery of medication directly to a patient's brain is achieved using an iontophoresis wire cooperable with a medication administration device. A controller regulates an electric charge to the iontophoresis wire. The iontophoresis wire is insertable into each nasal cavity. This wire is preferably encased in a tube, through which the medication will be transnasally delivered. A cleaning solution may also be delivered to the nasal cavity after treatment to reduce irritation from the iontophoresis.
    Type: Application
    Filed: May 14, 2010
    Publication date: March 15, 2012
    Inventor: Eduard N. Lerner
  • Patent number: 7593770
    Abstract: A delivery method and implantable apparatus that allows for controlled, enhanced and (pre)-programmable administration of a biologically active agent into the spinal structures and/or the brain via the epidural space of a mammal, particularly of a human being and including a feedback regulated delivery method and apparatus specifically in the treatment of neurological diseases and chronic pain.
    Type: Grant
    Filed: October 20, 2003
    Date of Patent: September 22, 2009
    Inventor: Eduard N. Lerner
  • Patent number: 7200432
    Abstract: A device and methods are described for a non-invasive transnasal and transocular drug delivery to the central nervous system using iontophoresis technology. By delivered through the olfactory nerve and the optical nerve, a biologically active substance of interest can be enhanced to be delivered into the CNS and CSF and bypassing the blood-brain barrier. Such drug delivery system can also be enhanced by using phonophoresis and other enhancement techniques.
    Type: Grant
    Filed: March 21, 2003
    Date of Patent: April 3, 2007
    Assignee: Intrabrain International NV
    Inventors: Eduard N. Lerner, Leonid Lerner
  • Patent number: 7033598
    Abstract: Disclosed are invasive and non-invasive central nervous system (CNS) drug delivery methods and devices for use in these methods that essentially circumvent the blood-brain barrier. More specifically, the disclosed methods and devices utilize iontophoresis as delivery technique that allows for enhanced delivery of a biologically active agent into the CNS of a mammal as well as for (pre)-programmable and controlled transport.
    Type: Grant
    Filed: January 18, 2002
    Date of Patent: April 25, 2006
    Assignee: Intrabrain International N.V.
    Inventor: Eduard N. Lerner
  • Patent number: 6913763
    Abstract: A delivery method and implantable apparatus that allows for controlled, enhanced and (pre)-programmable administration of a biologically active agent into the spinal structures and/or the brain via the epidural space of a mammal, particularly of a human being and including a feedback regulated delivery method and apparatus specifically in the treatment of neurological diseases and chronic pain.
    Type: Grant
    Filed: January 18, 2002
    Date of Patent: July 5, 2005
    Assignee: Intrabrain International NV
    Inventor: Eduard N. Lerner
  • Publication number: 20040064127
    Abstract: A delivery method and implantable apparatus that allows for controlled, enhanced and (pre)-programmable administration of a biologically active agent into the spinal structures and/or the brain via the epidural space of a mammal, particularly of a human being and including a feedback regulated delivery method and apparatus specifically in the treatment of neurological diseases and chronic pain.
    Type: Application
    Filed: October 20, 2003
    Publication date: April 1, 2004
    Applicant: Intrabrain NV
    Inventor: Eduard N. Lerner
  • Patent number: 6678553
    Abstract: A device and methods are described for a non-invasive transnasal and transocular drug delivery to the central nervous system using iontophoresis technology. By delivered through the olfactory nerve and the optical nerve, a biologically active substance of interest can be enhanced to be delivered into the CNS and CSF and bypassing the blood-brain barrier. Such drug delivery system can also be enhanced by using phonophoresis and other enhancement techniques.
    Type: Grant
    Filed: May 20, 1998
    Date of Patent: January 13, 2004
    Assignee: Intraabrain International NV
    Inventors: Eduard N. Lerner, Leonid Lerner
  • Publication number: 20030191426
    Abstract: A device to enhance the delivery of a drug or other substance of interest into a selected organ or tissue, comprising special electrodes, one of the electrodes carrying a container with the selected drug or other substance of interest, said electrodes being capable of being positioned at preselected locations of said organ or tissue, wherein the electrodes are all connected with a selected energy source which generates and maintains an energy field before and during the enhanced delivery of said substance, under the influence of which delivery is accomplished in a direction from the active to the passive electrode and into said organ or tissue. The energy source may be selected from suitable sources providing an electric field, a magnetic field, ultrasonic waves, high energy waves like laser beams, or a combination thereof.
    Type: Application
    Filed: March 21, 2003
    Publication date: October 9, 2003
    Applicant: Intrabrain International NV
    Inventors: Eduard N. Lerner, Leonid Lerner
  • Publication number: 20020183683
    Abstract: Disclosed are invasive and non-invasive central nervous system (CNS) drug delivery methods and devices for use in these methods that essentially circumvent the blood-brain barrier. More specifically, the disclosed methods and devices utilize iontophoresis as delivery technique that allows for enhanced delivery of a biologically active agent into the CNS of a mammal as well as for (pre)-programmable and controlled transport.
    Type: Application
    Filed: January 18, 2002
    Publication date: December 5, 2002
    Applicant: Intrabrain International NV
    Inventor: Eduard N. Lerner
  • Publication number: 20020123678
    Abstract: A device to enhance the delivery of a drug or other substance of interest into a selected organ or tissue, comprising special electrodes, one of the electrodes carrying a container with the selected drug or other substance of interest, said electrodes being capable of being positioned at preselected locations of said organ or tissue, wherein the electrodes are all connected with a selected energy source which generates and maintains an energy field before and during the enhanced delivery of said substance, under the influence of which delivery is accomplished in a direction from the active to the passive electrode and into said organ or tissue. The energy source may be selected from suitable sources providing an electric field, a magnetic field, ultrasonic waves, high energy waves like laser beams, or a combination thereof.
    Type: Application
    Filed: May 20, 1998
    Publication date: September 5, 2002
    Inventors: EDUARD N. LERNER, LEONID LERNER
  • Publication number: 20020082583
    Abstract: A delivery method and implantable apparatus that allows for controlled, enhanced and (pre)-programmable administration of a biologically active agent into the spinal structures and/or the brain via the epidural space of a mammal, particularly of a human being and including a feedback regulated delivery method and apparatus specifically in the treatment of neurological diseases and chronic pain.
    Type: Application
    Filed: January 18, 2002
    Publication date: June 27, 2002
    Applicant: Intrabrain International NV
    Inventor: Eduard N. Lerner
  • Patent number: 6410046
    Abstract: A device, methods and pharmaceutical compositions are disclosed for transnasal or transocular drug delivery to the central nervous system using a combination of electrotransport or phonophoresis with chemical permeation enhancers.
    Type: Grant
    Filed: November 20, 1998
    Date of Patent: June 25, 2002
    Assignee: Intrabrain International NV
    Inventor: Eduard N. Lerner
  • Publication number: 20020068080
    Abstract: A device, methods and pharmaceutical compositions are disclosed for transnasal or transocular drug delivery to the central nervous system using a combination of electrotransport or phonophoresis with chemical permeation enhancers.
    Type: Application
    Filed: November 20, 1998
    Publication date: June 6, 2002
    Inventor: EDUARD N. LERNER
  • Patent number: 5522386
    Abstract: Apparatus for use in the determination of the condition of the vegetative part of the nervous system and/or of sensory functions of an organism, i.e. a human being or animal. The apparatus comprises devices for generating and supplying to said organism at least one sensory stimulus chosen from a group of sensory stimuli, such as visual, sound, olfactory, gustatory, tactile or pain stimuli, and devices for measuring the skin potential and the evoked response of the organism to a stimulus. The measured data are processed by processing devices for automatically controlling the supply of at least one stimulus for providing a non-rhythmical sequence of stimuli. Preferably, pairs of stimuli are supplied for developing a conditioned reflex.
    Type: Grant
    Filed: November 24, 1993
    Date of Patent: June 4, 1996
    Inventor: Eduard N. Lerner
  • Patent number: 5482052
    Abstract: A method and an instrument for measuring sensory functions (hearing vision, smell, tactile sense and pain sensitivity) of a human or an animal, whereby the sense under investigation is stimulated and the resulting change of a skin potential is recorded. Preferably, another stimulus such as an electric potential is applied, optionally several times with varying intervals and varying intensity, prior to the stimulation of the sense under investigation.
    Type: Grant
    Filed: December 27, 1993
    Date of Patent: January 9, 1996
    Inventor: Eduard N. Lerner